Eamon M. Berge

1.4k total citations
14 papers, 540 citations indexed

About

Eamon M. Berge is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Eamon M. Berge has authored 14 papers receiving a total of 540 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 11 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Eamon M. Berge's work include Lung Cancer Treatments and Mutations (12 papers), Lung Cancer Research Studies (5 papers) and Colorectal Cancer Treatments and Studies (4 papers). Eamon M. Berge is often cited by papers focused on Lung Cancer Treatments and Mutations (12 papers), Lung Cancer Research Studies (5 papers) and Colorectal Cancer Treatments and Studies (4 papers). Eamon M. Berge collaborates with scholars based in United States, Italy and Australia. Eamon M. Berge's co-authors include Robert C. Doebele, D. Ross Camidge, Dara L. Aisner, Marileila Varella‐Garcia, Anh T. Le, Margaret C. Skokan, Marco Alloisio, Armando Santoro, Massimo Roncalli and Luigi Terracciano and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Eamon M. Berge

14 papers receiving 532 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eamon M. Berge United States	8	425	303	231	141	41	14	540
Lorin A. Ferris United States	8	512 1.2×	383 1.3×	250 1.1×	159 1.1×	70 1.7×	10	616
Kunitoshi Tomii Japan	4	480 1.1×	389 1.3×	269 1.2×	150 1.1×	34 0.8×	7	658
Chiara Bennati Italy	13	502 1.2×	406 1.3×	180 0.8×	158 1.1×	72 1.8×	40	632
Takashi Nakaoku Japan	10	384 0.9×	302 1.0×	247 1.1×	191 1.4×	49 1.2×	14	581
Minhao Fan China	6	268 0.6×	305 1.0×	175 0.8×	134 1.0×	55 1.3×	11	531
Stéphanie Deudon Switzerland	5	495 1.2×	481 1.6×	356 1.5×	177 1.3×	54 1.3×	10	786
Kevin Jao Canada	10	337 0.8×	293 1.0×	145 0.6×	142 1.0×	24 0.6×	23	476
Amanda C. Pawlak United States	4	423 1.0×	339 1.1×	180 0.8×	144 1.0×	62 1.5×	5	576
Philip Tracy United States	4	472 1.1×	354 1.2×	211 0.9×	168 1.2×	41 1.0×	7	534
Katherine R. Schultz United States	6	460 1.1×	358 1.2×	170 0.7×	128 0.9×	48 1.2×	8	511

Countries citing papers authored by Eamon M. Berge

Since Specialization

Citations

This map shows the geographic impact of Eamon M. Berge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eamon M. Berge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eamon M. Berge more than expected).

Fields of papers citing papers by Eamon M. Berge

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eamon M. Berge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eamon M. Berge. The network helps show where Eamon M. Berge may publish in the future.

Co-authorship network of co-authors of Eamon M. Berge

This figure shows the co-authorship network connecting the top 25 collaborators of Eamon M. Berge. A scholar is included among the top collaborators of Eamon M. Berge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eamon M. Berge. Eamon M. Berge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

McCoach, Caroline E., Eamon M. Berge, Xian Lu, Anna E. Barón, & D. Ross Camidge. (2015). A Brief Report of the Status of Central Nervous System Metastasis Enrollment Criteria for Advanced Non–Small Cell Lung Cancer Clinical Trials: A Review of the ClinicalTrials.gov Trial Registry. Journal of Thoracic Oncology. 11(3). 407–413. 43 indexed citations

Camidge, D. Ross, Eamon M. Berge, Robert C. Doebele, et al.. (2014). A Phase II, Open-Label Study of Ramucirumab in Combination with Paclitaxel and Carboplatin as First-Line Therapy in Patients with Stage IIIB/IV Non–Small-Cell Lung Cancer. Journal of Thoracic Oncology. 9(10). 1532–1539. 41 indexed citations

Poonia, Seerat, Eamon M. Berge, Dara L. Aisner, Denise Damek, & Robert C. Doebele. (2014). EGFR Exon 19 Deletion Mutations and Systemic/Central Nervous System Miliary Metastasis: Clinical Correlations and Response to Therapy. Clinical Lung Cancer. 15(5). 387–389. 6 indexed citations

Berge, Eamon M., Dara L. Aisner, & Robert C. Doebele. (2013). Erlotinib Response in an NSCLC Patient with a Novel Compound G719D+L861R Mutation in EGFR. Journal of Thoracic Oncology. 8(9). e83–e84. 8 indexed citations

Berge, Eamon M. & Robert C. Doebele. (2013). Targeted Therapies in Non-Small Cell Lung Cancer: Emerging Oncogene Targets Following the Success of Epidermal Growth Factor Receptor. Seminars in Oncology. 41(1). 110–125. 48 indexed citations

Berge, Eamon M. & Robert C. Doebele. (2013). Re-examination of Maintenance Therapy in Non-Small Cell Lung Cancer with the Advent of New Anti-cancer Agents. Drugs. 73(6). 517–532. 4 indexed citations

Berge, Eamon M., Daniel W. Bowles, Thomas W. Flaig, Elaine T. Lam, & Antonio Jimeno. (2013). Tivozanib: Practical implications for renal cell carcinoma andother solid tumors. Drugs of today. 49(5). 303–303. 7 indexed citations

Berge, Eamon M., Xian Lu, Anna E. Barón, et al.. (2013). Clinical Benefit From Pemetrexed Before and After Crizotinib Exposure and From Crizotinib Before and After Pemetrexed Exposure in Patients With Anaplastic Lymphoma Kinase-Positive Non–Small-Cell Lung Cancer. Clinical Lung Cancer. 14(6). 636–643. 20 indexed citations

Varella‐Garcia, Marileila, Liang Xu, Eamon M. Berge, et al.. (2013). RET rearrangements detected by FISH in “pan-negative” lung adenocarcinoma.. Journal of Clinical Oncology. 31(15_suppl). 8024–8024. 6 indexed citations

10.

Davies, Kurtis D., Anh T. Le, Mariana F. Theodoro, et al.. (2012). Identifying and Targeting ROS1 Gene Fusions in Non–Small Cell Lung Cancer. Clinical Cancer Research. 18(17). 4570–4579. 330 indexed citations

11.

Moran, Diarmuid, Patricia B. Trusk, Scott A. Shell, et al.. (2012). Abstract LB-449: KRAS mutation and amplification status predicts sensitivity to antifolate therapies in non-small-cell lung cancer. Cancer Research. 72(8_Supplement). LB–449. 3 indexed citations

12.

Doebele, Robert C., Dara L. Aisner, Anh T. Le, et al.. (2012). Analysis of resistance mechanisms to ALK kinase inhibitors in ALK+ NSCLC patients.. Journal of Clinical Oncology. 30(15_suppl). 7504–7504. 18 indexed citations

13.

Berge, Eamon M., Xian Lu, Anna E. Barón, et al.. (2012). Clinical benefit from pemetrexed before and after crizotinib exposure in patients with ALK positive non-small cell lung cancer (ALK+ NSCLC).. Journal of Clinical Oncology. 30(15_suppl). 7601–7601. 1 indexed citations

14.

Berge, Eamon M., et al.. (2011). Development of Novel Targeted Agents in the Treatment of Metastatic Colorectal Cancer. Clinical Colorectal Cancer. 10(4). 266–278. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact